RT Journal Article
SR Electronic
T1 A Systematic Review and Meta-Analysis of Automated Methods for Quantifying Enlarged Perivascular Spaces in the Brain
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.04.24303705
DO 10.1101/2024.03.04.24303705
A1 Jennifer M.J. Waymont
A1 Maria C. Valdés Hernández
A1 Jose Bernal
A1 Roberto Duarte Coello
A1 Rosalind Brown
A1 Francesca M. Chappell
A1 Lucia Ballerini
A1 Joanna M. Wardlaw
YR 2024
UL http://medrxiv.org/content/early/2024/03/04/2024.03.04.24303705.abstract
AB Research into magnetic resonance imaging (MRI)- visible perivascular spaces (PVS) has recently increased, as results from studies in different diseases and populations are cementing their association with sleep, disease phenotypes, and overall health indicators. With the establishment of worldwide consortia and the availability of large databases, computational methods that allow to automatically process all this wealth of information are becoming increasingly relevant. Several computational approaches have been proposed to assess PVS from MRI, and efforts have been made to summarise and appraise the most widely applied ones. We systematically reviewed and meta-analysed all publications available up to September 2023 describing the development, improvement, or application of computational PVS quantification methods from MRI. We analysed 67 approaches and 60 applications of their implementation, from 112 publications. The two most widely applied were the use of a morphological filter to enhance PVS-like structures, with Frangi being the choice preferred by most, and the use of a U-Net configuration with or without residual connections. Older adults or population studies comprising adults from 18 years old onwards were, overall, more frequent than studies using clinical samples. PVS were mainly assessed from T2-weighted MRI acquired in 1.5T and/or 3T scanners, although combinations using it with T1-weighted and FLAIR images were also abundant. Common associations researched included age, sex, hypertension, diabetes, white matter hyperintensities, sleep and cognition, with occupation-related, ethnicity, and genetic/hereditable traits being also explored. Despite promising improvements to overcome barriers such as noise and differentiation from other confounds, a need for joined efforts for a wider testing and increasing availability of the most promising methods is now paramount.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is mainly funded by the Hilary and Galen Weston Foundation under the Novel Biomarkers 2019 scheme (ref UB190097) administered by the Weston Brain Institute. This study received also funds from the Fondation Leducq Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease (16 CVD 05); the Row Fogo Charitable Trust (MCVH, FC, JMW) (BRO-D.FID3668413); and the UK Dementia Research Institute at the University of Edinburgh funded by the Medical Research Council, Alzheimers Society and Alzheimers Research UK (JMW, JMJW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This manuscript is a systematic review of the published literature on the theme. As such it uses only published data, and the doi of each publication analysed is given in the References section.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data extracted is given in the tables of the manuscript.